Hanpanich Orakan, Saito Ken, Shimada Naohiko, Maruyama Atsushi
Department of Life Science and Technology, Tokyo Institute of Technology, Nagatsuta 4259 B-57, Yokohama, 226-8501, Japan.
Department of Life Science and Technology, Tokyo Institute of Technology, Nagatsuta 4259 B-57, Yokohama, 226-8501, Japan.
Biosens Bioelectron. 2020 Oct 1;165:112383. doi: 10.1016/j.bios.2020.112383. Epub 2020 Jun 12.
RNA detection permits early diagnosis of several infectious diseases and cancers, which prevent propagation of diseases and improve treatment efficacy. However, standard technique for RNA detection such as reverse transcription-quantitative polymerase chain reaction has complicated procedure and requires well-trained personnel and specialized lab equipment. These shortcomings limit the application for point-of-care analysis which is critical for rapid and effective disease management. The multicomponent nucleic acid enzymes (MNAzymes) are one of the promising biosensors for simple, isothermal and enzyme-free RNA detection. Herein, we demonstrate simple yet effective strategies that significantly enhance analytical performance of MNAzymes. The addition of the cationic copolymer and structural modification of MNAzyme significantly enhanced selectivity and activity of MNAzymes by 250 fold and 2,700 fold, respectively. The highly simplified RNA detection system achieved a detection limit of 73 fM target concentration without additional amplification. The robustness of MNAzyme in the presence of non-target RNA was also improved. Our finding opens up a route toward the development of an alternative rapid, sensitive, isothermal, and protein-free RNA diagnostic tool, which expected to be of great clinical significance.
RNA检测有助于多种传染病和癌症的早期诊断,可预防疾病传播并提高治疗效果。然而,诸如逆转录定量聚合酶链反应等RNA检测的标准技术程序复杂,需要训练有素的人员和专门的实验室设备。这些缺点限制了即时检测分析的应用,而即时检测分析对于快速有效的疾病管理至关重要。多组分核酸酶(MNAzymes)是用于简单、等温且无酶RNA检测的有前景的生物传感器之一。在此,我们展示了显著提高MNAzymes分析性能的简单而有效的策略。阳离子共聚物的添加和MNAzyme的结构修饰分别使MNAzymes的选择性和活性显著提高了250倍和2700倍。高度简化的RNA检测系统在无需额外扩增的情况下实现了73 fM目标浓度的检测限。MNAzyme在非靶标RNA存在下的稳健性也得到了改善。我们的发现为开发一种替代性的快速、灵敏、等温且无蛋白质的RNA诊断工具开辟了一条途径,有望具有重大的临床意义。